Navigation Links
A new therapeutic target may prevent blindness in premature babies at risk of retinopathy
Date:9/16/2014

This news release is available in French.

According to a study conducted by pediatricians and researchers at Sainte-Justine University Hospital Research Center (Sainte-Justine) and Universit de Montral published online in the prestigious medical journal Nature Medicine on September 14, 2014, the activation of a receptor that migrates to the nucleus of nerve cells in the retina promotes the growth of blood vessels. The finding opens the possibility of developing new, more selective drugs to control the abnormal growth of blood vessels and prevent blindness including retinopathy of prematurity, a disorder that may result in retinal detachment due to abnormal blood vessel growth in the retina of the eye.

"This study shows that a single receptor may play various roles depending on whether its site of action is in the nucleus or on the cell membrane," states Dr. Jean-Sbastien Joyal, MD, PhD, a pediatric intensivist at the Sainte-Justine UHC and an assistant professor at the Universit de Montral. The groundbreaking discovery has significant clinical implications, since many drugs act on this family of receptors irrespective of their site of action in the cell. "Our results are extremely encouraging. They indicate that drugs formulated to target this nuclear receptor may one day prevent retinopathy in premature babies," continued Dr. Sylvain Chemtob, a neonatologist at Sainte-Justine and a full professor in Pediatrics, Ophthalmology and Pharmacology at the Universit de Montral.

Abnormal proliferation of blood vessels may lead to a number of disorders. Therefore, the finding may offer therapeutic potential for other conditions, particularly proliferative diabetic retinopathy and cancer. This potential still needs to be explored.


'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal
@uMontreal_news
Source:Eurekalert

Page: 1

Related medicine news :

1. Rutgers Presbyterian Church Announces the Expansion of Its Adult Wellness Initiative to Include Therapeutic Yoga
2. Home Healthcare Market By Product (Therapeutic, Diagnostic Equipment, Mobility Assist, Diabetes Monitor), By Service Is Expected To Reach USD 355.3 Billion By 2020
3. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
5. Finding new approaches for therapeutics against Ebola virus
6. InventHelp Inventors Develop Therapeutic Pillow (JMC-1491)
7. Therapeutic Insole Relieves Pain in the Foot, Knee, Hip and Back - Designed by InventHelp Client (HLW-1309)
8. Preclinical development of tumor therapeutic agent starts
9. Tumor blood vessel protein provides potential therapeutic target
10. Trigeminal Neuralgia (Prosopalgia) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org
11. Dermatophytic Onychomycosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... , ... Galena, Alaska, has a population of less than 500 people. But, ... targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The Galena ... describes the journey to get power to his small town, off the electrical grid. ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, ... investing in InsightRX, an early stage company in San Francisco that has developed ... Greatpoint Ventures Innovation Fund acted as the lead investor in the ...
(Date:5/21/2017)... ... 2017 , ... GetLinked® software continues to enhance ... systems. , Dozens of clubs using ABC Financial Services are now connected using ... their club’s accounting system , The latest implementation is Riverside Health Club ...
(Date:5/21/2017)... ... May 21, 2017 , ... For the ... cross-disciplinary group of scholars, policymakers, and activists wanting to address equity issues in ... is the third book from a recent series of from this conference. ...
(Date:5/21/2017)... ... , ... Following the tragic and widely publicized death of Rory Staunton, 12, ... hospitals follow a protocol to quickly identify and treat the condition. , The ... would have saved Rory or anyone else’s life. , Now, five years after ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed ... a health care service center company based in ... in relationship management programs for leading pharmaceutical manufacturers and ... WRB will join Envoy Health Management, LLC ... manufacturers, biotech firms, and other service companies. Together, WRB ...
(Date:5/6/2017)... May 5, 2017  May is Stroke Awareness Month ... the most important methods to prevent a stroke: monitor ... for Disease Control and Prevention, undetected and uncontrolled hypertension ... Omron, the global leader in personal heart health technology, ... of heart attack and stroke and is advancing a ...
(Date:5/4/2017)... Inc. (" Fortuna "), a private, clinical-stage biotech company, ... for embryonic and fetal stem cells by using direct reprogramming ... announced today the launch of its Scientific Advisory ... Father Kevin FitzGerald , S.J., PhD; Col. (R) ... , PhD. "We are excited and honored to ...
Breaking Medicine Technology: